Brown adipose tissue (BAT) promotes a lean and healthy phenotype and improves insulin sensitivity 1 . In response to cold or exercise, brown fat cells also emerge in the white adipose tissue (WAT; also known as beige cells), a process known as browning [2] [3] [4] . Here we show that the development of functional beige fat in the inguinal subcutaneous adipose tissue (ingSAT) and perigonadal visceral adipose tissue (pgVAT) is promoted by the depletion of microbiota either by means of antibiotic treatment or in germ-free mice. This leads to improved glucose tolerance and insulin sensitivity and decreased white fat and adipocyte size in lean mice, obese leptin-deficient (ob/ob) mice and high-fat diet (HFD)-fed mice. Such metabolic improvements are mediated by eosinophil infiltration, enhanced type 2 cytokine signaling and M2 macrophage polarization in the subcutaneous white fat depots of microbiota-depleted animals. The metabolic phenotype and the browning of the subcutaneous fat are impaired by the suppression of type 2 cytokine signaling, and they are reversed by recolonization of the antibiotic-treated or germfree mice with microbes. These results provide insight into the microbiota-fat signaling axis and beige-fat development in health and metabolic disease.
The intestinal microbiota is established as the host develops, and its composition is influenced by several physiological changes, including obesity and pregnancy [5] [6] [7] . The intestinal microbiota can also influence host metabolism 8 and insulin sensitivity 9, 10 . To address the metabolic effects of complete microbiota depletion, we used mice given an antibiotic cocktail supplement in drinking water (Abx) as well as germ-free (GF) mice. In agreement with previous work [10] [11] [12] , our results showed improvements in both insulin sensitivity and tolerance of oral and intraperitoneal glucose challenge in each animal model ( Fig. 1a-d and Supplementary Fig. 1a-d) . The insulin sensitivity of the microbiota-depleted Abx mice was further investigated using a hyperinsulinemic-euglycemic clamp in awake and unrestrained C57Bl6/J mice. Antibiotic administration led to a marked increase in the glucose infusion rates needed to maintain the clamped glucose levels and an increase in the stimulated rate of whole-body glucose disappearance (Rd) levels, whereas basal and final insulin levels were both lower ( Fig. 1e and Supplementary Fig. 2a,b) . These results demonstrate that microbiota depletion improves insulin sensitivity.
To investigate peripheral glucose uptake, we co-administered 2-[ 14 C]deoxyglucose (2-[ 14 C]DG) during the clamp. Whereas no changes were observed in glucose uptake from the interscapular BAT (iBAT), quadriceps muscle or brain or in hepatic glucose production, there was an increased uptake from the ingSAT and pgVAT and a decreased uptake from the soleus muscle ( Fig. 1f,g and Supplementary Fig. 2c-h) . These results suggest that the white-fat depots are the main glucose disposal tissues in hyperinsulinemic conditions, an idea that was further corroborated using positron emission tomography-computed tomography (microPET-CT). Specifically, [ 18 F]fluorodeoxyglucose ([ 18 F]FDG) uptake in iBAT increased after the mice were subjected to 12 h of cold exposure, but the change in uptake did not differ between the groups. By contrast, Abx mice showed increased [ 18 F]FDG uptake in both their ingSAT and pgVAT, and this was not changed by cold exposure ( Fig. 1h and Supplementary Fig. 3a-d Fig. 3e-j) . Together, these results demonstrate that microbiota depletion leads to increased glucose disposal primarily in the WAT depots, in both hyperinsulinemic and basal conditions. Antibiotic treatment in mice also led to a decrease in the volume and weight of ingSAT, pgVAT and interscapular SAT (iSAT) ( Fig. 1i and Supplementary Fig. 4a,b) , increased food intake and increased stool output ( Supplementary Fig. 4c-e ). These results were consistent with the data that we obtained from GF mice, and they were confirmed Microbiota depletion promotes browning of white adipose tissue and reduces obesity using multidetector computed tomography (CT) ( Supplementary  Fig. 4f,g) . Hounsfield unit analysis of the microPET-CT scans revealed that Abx mice had higher ingSAT and pgVAT density compared to that of controls, and that these differences were increased after the mice were subjected to 12 h of cold exposure ( Fig. 1j and Supplementary Fig. 3j ).
We next investigated whether the higher densities and decreased amounts of fat originated from differences in adipocyte volume. Measuring adipocyte size distribution using high-content imaging revealed that both Abx and GF mice had an increased number of small adipocytes and a decreased number of large adipocytes in the ingSAT and pgVAT depots compared to controls ( Fig. 2a,b ). Morphologically, there was an increased number of smaller adipocytes in both whitefat depots with a multilocular phenotype (Fig. 2c) , and the adipose depots that had been excised from microbiota-depleted animals were darker in appearance than those in untreated mice ( Supplementary  Fig. 4h ). These features are characteristic of mature beige adipocytes. Therefore, we investigated whether microbiota depletion could affect the browning of the white-fat depots. Both Abx and GF mice showed increases in brown fat-specific markers in the ingSAT and in the pgVAT depots ( Fig. 2d,e ). The increased ingSAT and pgVAT browning was confirmed by carrying out high-content imaging, and it suggested an increase in the number of uncoupling protein 1 (ucp1)positive cells in both of the microbiota-depleted animal models, accompanied by increased 3,5,3′-triiodothyronine (T3) levels in the GF mice ( Fig. 2f and Supplementary Fig. 5a-c) . These data suggest that microbiota depletion leads to browning of WATs in subcutaneous and visceral depots. The browning was already present 10 d after antibiotics administration, and it had further increased at 40 d and 60 d after the start of antibiotic treatment ( Fig. 2d and Supplementary  Fig. 5d-g) . Body-temperature measurements demonstrated that the initially more pronounced temperature drop that was observed in Abx mice after acute cold exposure normalized to control levels after 6 weeks of antibiotic treatment, even though these mice experienced lower energy harvest from food ( Supplementary Fig. 5h ,i) 13 . Accordingly, Abx mice that were repopulated with microbiota from control mice and that maintained the increased levels of browning markers 10 d after transplantation had increased glucose levels during periods of cold exposure, and they showed improved tolerance of acute cold ( Supplementary Fig. 5i -k); this suggests that their newly developed beige fat is functionally active. The increased thermogenic capacity was further confirmed by oxygen consumption rate (OCR) measurements after mice were subjected to isoproterenol stimulation; adipocytes isolated from the Abx mice showed a greater response than did those from control mice ( Fig. 2g) .
To investigate the reversibility of the browning after microbiota transplantation, we conventionalized GF mice with microbiota from control mice (GF conventionalized) or with residual microbiota from Abx mice. Expansion of the microbiota in the mice colonized with microbiota from Abx mice was either suppressed by administering continuous antibiotic treatment to the recipient GF mice (GFAbxT) or not suppressed (GFAbxTstop). Compared to GFAbxT mice, GFconventionalized mice and GFAbxTstop mice had decreased glucose tolerance and insulin sensitivity, increased white-fat weight and cell size and diminished browning (as assessed by brown fat-marker expression) at 5 weeks and 7.5 weeks after transplantation ( Fig. 2h-j and Supplementary Figs. 5l-o and 6a-d) . GFAbxT mice and GF mice did not show differences in their expression of browning markers or in the size of adipocytes, suggesting that the residual microbiota present after antibiotic treatment did not affect the increased browning observed in the GF mice ( Fig. 2j and Supplementary Fig. 6b-d) .
These results were consistent with those for the repopulated Abx mice, which showed decreased glucose tolerance, impaired insulin sensitivity and reversal of the browning of white-fat depots 30 d after npg repopulation ( Supplementary Fig. 6e-h) . We extended these studies to mice kept at thermoneutrality to ensure that any increased browning capacity would be driven by microbiota depletion alone, excluding the possible effects of environmental temperature 14 .
Microbiota depletion also led to increased glucose tolerance and insulin sensitivity under thermoneutral conditions, decreased amounts of ingSAT and pgVAT and smaller adipocytes, along with increased expression of browning markers, albeit to a lower magnitude than that seen in mice kept at room temperature, which is consistent with the absence of a mild thermal stimulation npg (Fig. 3a-c and Supplementary Fig. 7a-e ). Antibiotic treatment led to improvements in the glucose tolerance and insulin sensitivity as well as increased browning and thermogenic capacity in ob/ob and HFD-fed mice (Fig. 3d-j and Supplementary Fig. 7f-h) , demonstrating that microbiota depletion also promotes improved metabolic fitness of obese animals.
To assess the mechanisms of browning, we profiled cytokine levels in the ingSAT, and we found that the levels of several type 1 and 2 cytokines were elevated in Abx mice as compared to untreated mice (Supplementary Fig. 8 ). Eosinophils and the type 2 cytokines interleukin (IL)-4, IL-13 and IL-5 are each alone sufficient to promote the development of beige fat through alternative activation of M2 macrophages expressing tyrosine hydroxylase (TH) [15] [16] [17] [18] , a rate-limiting enzyme in catecholamine biosynthesis 19 . These were the most significantly upregulated cytokines in the ingSAT after microbiota depletion in Abx mice (Fig. 4a) , but not in the intestine of the same animals (Supplementary Fig. 8) . Th mRNA and TH protein levels were increased in ingSAT after 10 d, and these increases were still present at 40 d and 60 d of microbiota depletion ( Fig. 4b-d ). The levels of type 2 cytokines were also increased in the pgVAT but only mildly so in the iBAT (Supplementary Fig. 9a,b) . By using flow cytometry, we detected an increased frequency of eosinophils and macrophages in the ingSAT, but not in the iBAT, of the microbiota-depleted mice. This was accompanied by an enhanced presence of CD301 and TH-positive M2-polarized macrophages in the ingSAT (Fig. 4e-g and Supplementary Fig. 9c-k) , suggesting that alternatively activated macrophages are associated with the increased browning of ingSAT. Accordingly, when compared to the microbiota-depleted wild-type mice, antibiotic-treated, IL-4 receptor alpha-knockout (Il4ra-KO, Il4ra −/− ) mice showed suppressed tolerance of cold and glucose and decreased insulin sensitivity, glucose uptake, and browning of ingSAT but not of pgVAT (Fig. 4h,i and Supplementary  Fig. 10a-i) . The loss of metabolic improvements in Il4ra-KO mice suggests that the ingSAT dominantly contributes to the observed metabolic effects of microbiota depletion, and it indicates that additional mechanisms might mediate pgVAT browning 20 . Finally, increased levels of eosinophil and TH-positive M2-polarized macrophages were also detected in the ingSAT, but not in the pgVAT, of the thermoneutral mice after microbiota depletion ( Fig. 4j and  Supplementary Fig. 10j-l) , demonstrating that the increased ing-SAT browning and glucose phenotypes after microbiota depletion are mediated by the increased type 2 cytokine signaling in both roomtemperature and thermoneutral mice.
Together, our results demonstrate that microbiota depletion stimulates beige-fat development in the ingSAT and the pgVAT, concomitant with increased type 2 cytokine signaling in these tissues. Inhibition of this signaling impairs antibiotic-induced subcutaneous-fat browning, and it suppresses the glucose phenotype of the microbiota-depleted mice. This alternative beige fat and macrophage activation offers new insights into the microbiota-fat signaling axis, beige-fat development and insulin sensitivity, and it suggests novel therapeutic approaches for the treatment of obesity and its associated metabolic disorders.
MeTHodS
Methods and any associated references are available in the online version of the paper. 
oNLINe MeTHodS
Animals. All C57Bl/6J (wild-type (wt)), BALB/c and Il4ra −/− mice were purchased from Charles River, France; ob/ob mice and respective C57Bl/6J controls were acquired from Janvier Labs (France). Mice were kept in a specific pathogen-free facility (SPF) in 12-h day and night cycles, and they were fed standard chow or a high-fat diet (60% Kcal fat, D12492, Ssniff, Germany). Germ-free (GF) mice were on C57Bl/6 background from the germ-free facility of the University of Bern, Switzerland, and were kept in sterile conditions in 12-h day and night cycles until killed, unless otherwise stated. Antibiotics were administered in the drinking water ad libitum and replaced with freshly prepared cocktails every second day, similarly to what has been described previously 21 , containing 100 µg per ml Neomycin, 50 µg per ml Streptomycin, 100 U per ml Penicillin, 50 µg per ml Vancomycin, 100 µg per ml Metronidazole, 1 mg per ml Bacitracin, 125 µg per ml Ciprofloxacin, 100 µg per ml Ceftazidime and 170 µg per ml Gentamycin (when longer than 40 d treatment) (Sigma, Germany; Alkaloid, Macedonia). All antibiotic treatments were started in 8-week-old animals, and all experiments were done in male mice. Cold and thermoneutral exposures were performed at 6 °C and 30 °C respectively, in a light-and humidity-controlled climatic chamber (TSE, Germany) in SPF conditions. Acclimatized animals were allocated to groups on the basis of their body weights and blood glucose levels to ensure equal starting points. All mice were kept two per cage. All animal experiments were approved by the Swiss federal and Geneva cantonal authorities for animal experimentation (Office Vétérinaire Federal and Commission Cantonale pour les Expériences sur les Animaux de Genève).
Microbiota repopulation.
Abx-treated mice were repopulated with microbiota from their conventional former littermates by co-housing them for 7 d immediately after withdrawal of antibiotics. Mice were analyzed at the times indicated in the experiments. For GF repopulation, 500 µl of freshly extracted cecal contents from either conventional or Abx mice were resuspended in 5 ml of anaerobic PBS, and 100 µl of the solution was inoculated by oral gavage at days 0 and 2 in each mouse. Animals were kept for 7 d in dirty cages from donor group. Repopulation was confirmed by qPCR.
Hyperinsulinemic-euglycemic clamp. Euglycemic-hyperinsulinemic clamps were performed in conscious, unrestrained, catheterized mice at the glucoseinsulin clamp platform, University of Geneva. Seven days before the experiment, mice were anesthetized using isoflurane, and a silastic catheter (0.012 inch inner diameter) was surgically implanted in the right jugular vein and exteriorized above the neck using vascular access button (Instech Laboratories Inc., Plymouth Meeting, PA). Mice were fasted for 5 h before the start of the experiment (t = 0 min). At t = −120 min, an infusion of [1-3 H] glucose (0.05 µCi per min) (PerkinElmer, Waltham, MA, USA) was initiated. After 120 min, blood samples were collected from the tail vein to measure basal blood glucose and plasma insulin as well as to calculate the rate of endogenous glucose appearance (EndoRa) and glucose disposal (Rd) at basal state. At t = 0 min, a continuous insulin infusion (4 mIU per kg body weight per min) (NovoRapid, Novo Nordisk Pharma, Zurich, Switzerland) was used to induce hyperinsulinemia. The infusion of [3-3 H] glucose was increased to 0.1 µCi per min and 50% glucose was infused to maintain target euglycemia (120 mg per dL) (glucose infusion rate, GIR). At steady state, insulinstimulated glucose uptake in tissues in vivo was determined by using a 10 µCi bolus injection of 2- 
Positron emission tomography-computed tomography (microPET-CT).
Mice were anesthetized with 2% isoflurane and were injected in the venous sinus with 5 MBq of 2-deoxy-2-[ 18 F]fluoro-d-glucose ([ 18 F]FDG). Mice were then left awake at room temperature or at 4 °C during the uptake time of 60 min. 10 min before undergoing positron emission tomography (PET) scans, mice were injected intraperitoneally with 700 µL of 132 mg per mL meglumine ioxitalamate (Telebrix, 6% m/v iodide, Guerbet AG, Zürich, Switzerland) to delineate the abdominal region, and they were subjected to computed tomography (CT) scans in a Triumph microPET/SPECT/CT system (Trifoil, Chatsworth, CA, USA). Images were obtained at 80 kVp, 160 µA, and 1024 projections were acquired during the 360° rotation with a field of view of 71.3 mm (1.7× magnification). After 60 min of [ 18 F]FDG uptake, PET scans were started for a total duration of 20 min. PET scans were reconstructed using the built-in LabPET software using an OSEM3D (20 iterations) algorithm, and images were calibrated in Bq per mL by scanning a phantom cylinder. The Triumph XO software, which uses a back-projection engine, was used to reconstruct the CT scans with a matrix of 512 and a voxel size of 0.135 mm. CT scans were co-registered with the PET scans using the plugin Vivid (Trifoil) for Amira (FEI, Hillsboro, OR, USA), and these were exported as dicom files. The software Osirix (Pixmeo, Bernex, Switzerland) was used to quantitatively analyze the data sets and generate pictures. Regions of interest (ROI) were drawn on contiguous slices on CT scans and computed as threedimensional (3D) volumes for the measurements of volumes and densities of indicated adipose tissues. Then, PET series were converted to display standardized uptake values (SUVs) that had been adjusted to the body weight of the animals and merged with CT sets. 3D ROIs derived from CT scans were used to quantify the uptake of [ 18 F]FDG in the indicated adipose tissues. To measure the volume of activated interscapular BAT, a 3D ROI was first delineated visually by contouring the [ 18 F]FDG activity. A new ROI was then derived on the basis of a threshold equal to the mean [ 18 F]FDG minus one s.d. of all voxels within the primary defined ROI. This final volume was used to report the activated BAT.
2-[1-3 H]Deoxyglucose (2DG) uptake.
Insulin-stimulated glucose uptake in tissues in vivo during the IPGTT was determined by using concomitant injection of 40 µCi of 2DG (PerkinElmer) with the glucose load (intraperitoneally (i.p.), 2 g per kg body weight). 2DG-specific activity was determined in deproteinized blood samples collected from the tail vein 5, 15, 30 and 45 min after injection. At 45 min, mice were rapidly killed, and tissues were removed and stored at −80 °C until use. Measurements of 2-[1-3 H]deoxyglucose-6-phosphate concentration enabled calculation of the glucose utilization index by individual tissues.
Flow cytometry and characterization of hematopoietic cell populations.
Primary stromal vascular fractions (SVF) from the ingSAT, pgVAT and iBAT were prepared as described 22,23 . Cells were washed in phosphate-buffered saline (PBS) supplemented with 0.1% BSA and 0.5 mM EDTA, pH 8.0, and they were stained when appropriate with rat monoclonal anti-F4/80 (Clone A3-1, cat # ab105155, 1:200, Abcam), rat monoclonal anti-CD11b (Clone M1/70, cat # 561114, 1:200, BD Biosciences) and rat monoclonal anti-CD301 (Clone LOM-14, cat # 145705, 1:400, BioLegend) for macrophage staining, or rat monoclonal anti-CD45 (Clone 104, cat #558702, 1:200, BD Biosciences) and rat monoclonal anti-Siglec F (Clone E50-2440, cat # 562068, 1:200, BD Biosciences) for eosinophil staining. For intracellular markers, cells were subsequently washed again, fixed in 2% paraformaldehyde, then labeled with rat monoclonal anti-NOS2 (Clone CXNFT, cat # 61-5920, eBioscience) and rabbit monoclonal anti-TH (Clone EP1533Y, cat # TA303716, 1:50, Origene) and polyclonal goat anti-rabbit secondary antibody (cat # A-10931, 1:400, Thermo Fisher Scientific) in permeabilization buffer (PBS with 0.5% Tween 20). Data were acquired using a Gallios Flow Cytometer (Beckman Coulter) and analyzed using FlowJo v10 software. After gating out dead cells and doublets, we identified macrophages as CD11b + F4/80 + and eosinophils were detected as CD45 + Siglec-F + cells.
Calorie uptake. Mice were housed two per cage, and food intake and feces production were measured and collected every 24 h. The feces were dried and ground to a fine powder before being subjected to an oxygen bomb calorimeter (Parr, 6100, USA) according to the manufacturer's instructions. Calorie excretion was calculated by multiplying the amount of feces produced by the caloric content per gram feces. npg Histology, immunofluorescence and Western blotting (WB). Tissues were extracted, fixed in 4% paraformaldehyde (Sigma), paraffin embedded, cut in 5 µm thick sections and stained with H&E using standard techniques. Immunohistochemistry was done using rabbit anti-UCP1 (Pierce PA1-24894, 1:100) and anti-rabbit Cy3 (Jackson 711165152, 1:250) secondary antibody. Images were acquired using Mirax (Zeiss) and the cell/lipid droplet size quantification was performed using MetaMorph software (V7.7.6.0, Molecular Devices). WB was done on 10-20 µg total lysates using rabbit anti-TH (OriGene TA303716, 1:1,000) and mouse anti-γ-tubulin (Sigma T6557, 1:5,000).
Metabolic experiments. Body temperatures were read with infrared camera FLIR E60 (FLIR, UK) from a distance of 40 cm and the data was analyzed by using FLIR Tools+ software. We confirmed the consistency with the results by taking rectal body-temperature measurements. Glucose tolerance tests were performed after 6 h fasting by intraperitoneal injection or oral gavage of glucose bolus (2 g per kg body weight). Insulin tolerance tests were performed after a 5-hour daytime fast, 0.5 U per kg except for HFD-fed mice (0.75 U per kg) and ob/ob mice (2 U per kg) (Sigma-Aldrich I9278). All mice were killed after 5 h of fasting. 500 µl of blood was taken from terminally anesthetized mice in tubes with 15 µl of 0.5 mM EDTA, 4 µl of aprotinin and 4 µl of DPPIV and plasma stored at −80 °C. Serum T3. Serum concentration of T3 (MyBioSource) was detected by following the manufacturer's instructions.
Oxygen consumption rates (OCR). Oxygen consumption of isolated mature adipocytes from the ingSAT was measured in Clark-type electrode (Rank Brothers Ltd., Cambridge, UK). Mature adipocytes were separated from SVF as previously described 22-24 , and they were resuspended in respiration buffer (250 mM sucrose, 50 mM KCl, 20 mM Tris/HCl, 1 mM MgCl 2 , 5 mM KH 2 PO 4 and 20 µM EGTA at pH 7.0). Respiration was assessed at basal state, and under β-adrenergic stimulation (10 µM isoproterenol). 20 mM oligomycin, 100 nM carbonyl cyanide-4-phenylhydrazone (FCCP) and 20 µM rotenone were added in 5-15-min intervals. Consumption values were normalized to extracted DNA from final mixture. Oxygen consumption was repeated two times for each replicate.
Real-time PCR. One µg of total RNA was used for cDNA preparation with random hexamer primers using a High Capacity cDNA Reverse Transcription kit (Applied Biosystems). Steady-state mRNA expression was measured by quantitative real-time PCR using the LightCycler 480 SYBR Green Master I Mix (Roche) with a Mx3005P Real-Time PCR System (Stratagene) or a 386-well LightCycler 480 II (Roche). Transcript levels were normalized to house keeping β-2-microglobulin (B2m). Primer sequences for real-time PCRs are as previously used 22,23 , together with the following for Th: 5′-GGTATACGCCACGCTGAAGG-3′ (F) and 5′-TAG CCACAGTACCGTTCCAGA-3′ (R). 
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